Literature DB >> 2671367

Antinuclear antibody in juvenile rheumatoid arthritis sera reacts with 50-40 kDa antigen(s) found in HeLa nuclear extracts.

P L Haber1, T G Osborn, T L Moore.   

Abstract

To identify whether sera containing antinuclear antibody (ANA) from patients with juvenile rheumatoid arthritis (JRA) recognize a common antigen, extracts of HeLa nuclei were prepared by incubating the nuclei with buffers of sequentially increasing salt concentrations (0.1 M, 0.3 M, and 0.5 M NaCl). Western blot analysis using sera from 82 patients with JRA revealed that 63% of ANA positive JRA sera reacted with 2 bands (50-40 kDa) in the 0.3 M extract whereas only 14% of ANA negative JRA sera had antibody to these bands. Antibody to the 50-40 kDa antigen(s) strongly correlated with the presence of ANA by immunofluorescence and was found in 70% of patients with iritis; however, it did not correlate with disease subgroup or disease activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2671367

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  The DEK nuclear autoantigen is a secreted chemotactic factor.

Authors:  Nirit Mor-Vaknin; Antonello Punturieri; Kajal Sitwala; Neil Faulkner; Maureen Legendre; Michael S Khodadoust; Ferdinand Kappes; Jeffrey H Ruth; Alisa Koch; David Glass; Lilli Petruzzelli; Barbara S Adams; David M Markovitz
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

Review 2.  Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.

Authors:  L I Sakkas; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

3.  Autoantibodies in patients with juvenile chronic arthritis and their immediate family relatives.

Authors:  T R Southwood; P J Roberts-Thomson; M J Ahern; K Shepherd; R McEvoy; J B Ziegler; J Edmonds
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

4.  The putative oncoprotein DEK, part of a chimera protein associated with acute myeloid leukaemia, is an autoantigen in juvenile rheumatoid arthritis.

Authors:  H Sierakowska; K R Williams; I S Szer; W Szer
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

5.  Autoantibodies to DNA topoisomerase II in juvenile rheumatoid arthritis.

Authors:  K L Zuklys; I S Szer; W Szer
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.